A Case Study: Henoch-Schonlein Purpura in a Geriatric Patient with Gastrointestinal Involvement

HENOCH-SCHONLEIN

  • Suberna Basnet Department Of Pharmacy Practice, Aditya College Of Pharmacy, Surampalem, Andhra Pradesh, India.
    suberna.basnet0009@gmail.com
  • Sanjana Department Of Pharmacy Practice, Aditya College Of Pharmacy, Surampalem, Andhra Pradesh, India.
  • Yallasai Vijaya durga Department Of Pharmacy Practice, Aditya College Of Pharmacy, Surampalem, Andhra Pradesh, India.
  • Allu Tejaswi Department Of Pharmacy Practice, Aditya College Of Pharmacy, Surampalem, Andhra Pradesh, India.
  • Amit Kumar Department Of Pharmacy Practice, Aditya College Of Pharmacy, Surampalem, Andhra Pradesh, India.

Abstract

IgA-mediated immune vasculitis known as Henoch-Schonlein purpura affects the small blood vessels in the joints, kidneys, GI tract, skin, and, less frequently, the brain and lungs. The present case report describes a 62-year-old female patient with Henoch-Schonlein purpura (HSP). HSP is a type of vasculitis that affects small vessels and is characterized by purpura, arthritis, abdominal pain, and kidney involvement. In this case, the patient presented with a rash with red lesions on the upper and lower limbs, crusted lesions on both lower limbs, and acute onset abdominal pain with hematochezia. Endoscopy revealed diffuse ulcerations in the stomach, duodenum, and right colon(fig.1). Biopsies revealed a leukocytoclastic vasculitis in the skin (fig2) and gastrointestinal tract.  The patient had a history of hypertension and smoking, and laboratory investigations revealed leucocytosis, anaemia, and electrolyte imbalances. The diagnosis of HSP was made based on the clinical presentation, laboratory findings, and biopsy results. The patient was treated with a combination of steroids, antibiotics, and supportive care, which led to significant improvement of symptoms and laboratory findings. Steroid therapy was given according to guidelines for the treatment of HSP, and tapering the steroid therapy helped to improve gastrointestinal symptoms. The case report highlights the importance of careful monitoring and appropriate treatment of HSP in geriatric patients, as well as the potential benefits of immunosuppressant therapy.

Keywords: Henoch-Schonlein, leukocytoclastic vasculitis, gastrointestinal tract, Eosinophilic Colitis, use of steroid like . Dexamethasone

Downloads

Download data is not yet available.

References

1. Amit B. Sohagia,Srinivas Guptha Gunturu Henoch-Schonlein Purpura—A Case Report and Review of the Literature. Hindawi Gastroenterology research and practice ,Volume 2010 | Article ID 597648 | https://doi.org/10.1155/2010/597648
2. Arinditia Triasti Putri and Awalia Diagnosis and management of Henoch-Schonlein purpura in Indonesian elderly with severe complication: A rare case. PMC pubmed. Published online 2022 Apr 20. doi: 10.1016/j.amsu.2022.103650
3. Afecto, Edgar MD; João, David Afonso MD Henoch-Schönlein Purpura in the Elderly–Rare and Deadly. The American journal of gastroenterology. DOI: 10.14309/ajg.0000000000001648
4. E. C. Ebert, “Gastrointestinal manifestations of Henoch-Schönlein purpura,” Digestive Diseases and Sciences, vol. 53, no. 8, pp. 2011–2019, 2008.
View at: Publisher Site | Google Scholar
5. E. J. Tizard and M. J. J. Hamilton-Ayres, “Henoch-Schönlein purpura,” Archives of Disease in Childhood: Education and Practice, vol. 93, pp. 1–8, 2008.
View at: Google Scholar
6. P. F. Roberts, T. A. Waller, T. M. Brinker, I. Z. Riffe, J. W. Sayre, and R. L. Bratton, “Henoch-Schönlein purpura: a review article,” Southern Medical Journal, vol. 100, no. 8, pp. 821–824, 2007.
View at: Publisher Site | Google Scholar
7. R. A. Watts and D. G. Scott, “Epidemiology of the vasculitides,” Seminars in Respiratory and Critical Care Medicine, vol. 25, no. 5, pp. 455–464, 2004.
View at: Google Scholar
8. A. Gedalia, “Henoch-Schönlein purpura,” Current Rheumatology Reports, vol. 6, no. 3, pp. 195–202, 2004.
View at: Google Scholar
9. Y. Zhang and X. Huang, “Gastrointestinal involvement in Henoch-Schönlein purpura,” Scandinavian Journal of Gastroenterology, vol. 43, no. 9, pp. 1038–1043, 2008.
View at: Publisher Site | Google Scholar
10. J. A. Mills, B. A. Michel, D. A. Bloch et al., “The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1114–1121, 1990.
View at: Google Scholar
11. S. Ozen, M. J. Dillon, A. Bagga et al., “EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides,” Annals of the Rheumatic Diseases, vol. 65, pp. 936–941, 2006.
View at: Google Scholar
12. J. Ronkainen, O. Koskimies, M. Ala-Houhala et al., “Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial,” Journal of Pediatrics, vol. 149, no. 2, pp. 241–247, 2006.
View at: Publisher Site | Google Scholar
13. P. F. Weiss, J. A. Feinstein, X. Luan et al., “Effects of corticosteroids on Henoch-Schönlein purpura: a systematic review,” Pediatrics, vol. 120, pp. 1079–1087, 2007.
View at: Google Scholar
Statistics
401 Views | 373 Downloads
How to Cite
basnet, suberna, na, S., yalla sai, vijaya D., Allu, T., & kumar, A. (2023). A Case Study: Henoch-Schonlein Purpura in a Geriatric Patient with Gastrointestinal Involvement: HENOCH-SCHONLEIN. Asian Journal of Hospital Pharmacy, 3(1), 5-8. https://doi.org/10.38022/ajhp.v3i1.72
Section
Case Reports